TXNDC5 and gastric adenocarcinoma: found that TXNDC5 is highly expressed in gastric cancer cells by immunohistochemistry and its expression is significantly increased in poorly differentiated adenocarcinomas, suggesting that the expression of TXNDC5 is significantly associated with the prognosis of gastric adenocarcinomas at the cardia (133).